Element | Comment |
---|---|
Clinical features | Recognized by a falling platelet count (platelet count falls by >50% to <150×109/L) in a patient receiving unfractionated or (much more rarely) low-molecular-weight heparin, with or without previous exposure to heparin. Thrombotic complications (venous and arterial) occur in 2050%. Bleeding is rare. Probability of diagnosis can be assessed by 4T score (Table ). Diagnosis proved by the presence of heparin-dependent antibodies. |
Differential diagnosis | Sepsis Post-transfusion purpura Thrombocytopenia caused by other drugs |
Management | Seek urgent advice from a haematologist Stop heparin Use alternative anticoagulant therapy with direct-acting thombin inhibitor (e.g. bivalirudin) or heparinoid (danaparoid) if needed The platelet count typically recovers within 414 days after stopping heparin The risk of thrombosis persists for up to several weeks |